Thomas Polascik
@thomaspolascik
Urologic oncologist and researcher @DukeGUCancer @DukeCancer; specializing in prostate and kidney tumors. All Tweets & opinions my own; RTs not endorsements.
ID: 936692363057156096
https://medschool.duke.edu/about-us/our-faculty/thomas-james-polascik 01-12-2017 20:23:57
66 Tweet
398 Followers
64 Following
The debate between legends in the field on FT vs RP. Mark Emberton va Carroll, Peter at #focal2020. Focal Therapy Society
Glad to have the FDA at #focal2020 to explain the interest to incorporate patient preference perspectives for novel PCa therapies #prostatecancer DCI Center for Prostate & Urologic Cancers Focal Therapy Society
Amazing 12th International Symposium Focal Therapy and Imaging held at the beautiful city of Washington! Hottest topics and brilliant lectures from the top leaders in the field from all over the world! Focal Therapy Society #focal2020 Thomas Polascik Dr. Art Rastinehad Rafael Sanchez-Salas
Dr Moul has successfully integrated Decipher testing in men who would benefit from a biomarker to help with pt decision making Duke Urology DCI Center for Prostate & Urologic Cancers #prostatecancer
Join a superstar faculty for hands on transperineal and ablation (Hifu/Cryo) Boston Scientific Urology Perineologic® Hashim U. Ahmed John Wei Michael Gorin, M.D. Abhinav Sidana @SonaCareMedical EDAP TMS Boston Scientific Urology Samir Taneja Chad Ellimoottil, MD, MS Lindsey Herrel Eric Barret Arieh Shalhav Thomas Polascik Derek Lomas
Hemigland cryoablation of localized #prostatecancer provides effective midterm oncologic outcomes with good continence and potency. Higher baseline PSA density is risk factor for recurrence and treatment failure. USC Urology Focal Therapy Society Journal of Urology
Thomas Polascik, of DCI Center for Prostate & Urologic Cancers and Duke Cancer, discusses efforts that are being made to harmonize genetic testing guidelines in prostate cancer. #pcsm ow.ly/jnmd50zkX1L
Ecstatic for DCI Center for Prostate & Urologic Cancers Duke Radiology Duke Urology @dukecancer Thomas Polascik to be part of this fantastic & critically important study in Radiology on #prostatemri. Thanks to SAR Prostate DFP colleagues & @acw_rad Daniel Margolis & Baris Turkbey MD for your leadership!
I love my Duke Urology #StreamTeam 💙 When it comes to our residents, I‘d trust them to operate on my kid AND I’d enjoy a beer with every single one of them (not concurrently). The perfect blend #Urosome
12th International Symposium on #FocalTherapy and #Imaging in #Prostate and #Kidney #Cancer. John Fortin discusses the latest developments and key takeaways in both therapy and imaging. #ReadNow > bit.ly/2VRKGbw Focal Therapy Society Endourological Society Thomas Polascik Dr. Art Rastinehad
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized PCa: An International Multidisciplinary Consensus Amir Lebastchi, MD Arvin K. George, MD Thomas Polascik Michael Gorin, M.D. RodolfoSanchez-Salas Peter Choyke buff.ly/3cRtmKj
Join us Fri Oct 16 12pm ET "How to Start a Focal Therapy Program" Register here: blbmeetings.zoom.us/webinar/regist… Focal Therapy Society
Congratulations to all Duke Distinguished Professors 🎉I am honored to be among the ranks as the Lawrence C Katz Distinguished Professor of Urologic Surgery. Thank you to those who supported me along this journey - the list is long! Duke University School of Medicine Duke Cancer